Literature DB >> 15939453

Human exposure and health risk of alpha-, beta-, gamma- and delta-hexachlorocyclohexane (HCHs) in Tianjin, China.

Y Yang1, S Tao, P K Wong, J Y Hu, M Guo, H Y Cao, R M Coveney, Q Zuo, B G Li, W X Liu, J Cao, F L Xu.   

Abstract

The dynamic exposures to HCHs of individuals born between the years 1913 and 1993 in Tianjin have been simulated by connecting a fugacity model (IV) with a multimedia exposure model. Ingestion is the most important pathway for human beings to take up HCHs, and concentrations in the human body correlate with body weight changes. Accumulations of HCHs were derived assuming that the degradation in human body behaved linearly. The health risk of exposure to HCHs was measured using cancer risk and loss of life expectancy (LLE), and LLE was modified from its original definition to incorporate a dynamic calculation that takes variances in exposure into account. Monte-Carlo simulations were run to analyze the uncertainties of the model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939453     DOI: 10.1016/j.chemosphere.2005.04.024

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  3 in total

1.  Assessment of Industry-Induced Urban Human Health Risks Related to Benzo[a]pyrenebased on a Multimedia Fugacity Model: Case Study of Nanjing, China.

Authors:  Linyu Xu; Huimin Song; Yan Wang; Hao Yin
Journal:  Int J Environ Res Public Health       Date:  2015-05-29       Impact factor: 3.390

2.  Relationship Between the Content of Chlorinated Hydrocarbons and Fatty Acid Composition of Milk Fat.

Authors:  Renata Pietrzak-Fiećko
Journal:  J Vet Res       Date:  2018-03-30       Impact factor: 1.744

3.  Predictors of Beta-Hexachlorocyclohexane blood levels among people living close to a chemical plant and an illegal dumping site.

Authors:  S Narduzzi; F Fantini; F Blasetti; P Rantakokko; H Kiviranta; F Forastiere; P Michelozzi; D Porta
Journal:  Environ Health       Date:  2020-01-22       Impact factor: 5.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.